AI Market Mood: Stock Dashboard
LXRX
Fundamental
Company: Lexicon Pharmaceuticals Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -0.14
Insider Own: 57.57%
Shs Outstand: 363.47M
Perf Week: -7.69%
Market Cap: 660.94M
Forward P/E: -
EPS next Y: -0.21
Insider Trans: 0.85%
Shs Float: 179.78M
Perf Month: 2.63%
Enterprise Value: 626.95M
PEG: -
EPS next Q: -0.03
Inst Own: 21.52%
Short Float: 12.87%
Perf Quarter: 35.65%
Income: -50.34M
P/S: 13.27
EPS this Y: -26.49%
Inst Trans: -29.70%
Short Ratio: 8.42
Perf Half Y: 27.87%
Sales: 49.80M
P/B: 5.27
EPS next Y Percentage: -16.35%
ROA: -20.83%
Short Interest: 23.14M
Perf YTD: 35.65%
Book/sh: 0.30
P/C: 6.87
EPS next 5Y: 8.44%
ROE: -39.72%
52W High: 1.83 -14.75%
Perf Year: 352.30%
Cash/sh: 0.23
P/FCF: -
EPS past 3/5Y: 39.13% 23.47%
ROIC: -30.78%
52W Low: 0.32 387.50%
Perf 3Y: -30.97%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: 610.25% 15.72%
Gross Margin: 98.20%
Volatility W: 6.53%
Volatility M: 7.94%
Perf 5Y: -76.68%
Dividend TTM: -
EV/Sales: 12.59
EPS Y/Y TTM: 78.37%
Oper. Margin: -98.21%
ATR (14): 0.12
Perf 10Y: -87.19%
Dividend Ex-Date: -
Quick Ratio: 4.87
Sales Y/Y TTM: 60.24%
Profit Margin: -101.08%
RSI (14): 50.47
Recom: 1.80
Dividend Gr. 3/5Y: - -
Current Ratio: 4.88
EPS Q/Q: 54.28%
SMA20: -2.65%
Beta: 0.94
Target Price: 3.36
Payout: -
Debt/Eq: 0.58
Sales Q/Q: -79.31%
SMA50: 7.26%
Rel Volume: 2.43
Prev Close: 1.62
Employees: 81
LT Debt/Eq: 0.52
Earnings: Mar 05 BMO
SMA200: 24.06%
Avg Volume: 2.75M
Price: 1.56
IPO: Apr 07, 2000
Option/Short: Yes / Yes
EPS/Sales Surpr.: 42.03% 74.85%
Trades:
Volume: 6,680,156
Change: -3.70%
Technical:
Latest News:
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare ... neutral
LXRX
Summary: Lexicon Pharmaceuticals, Inc. announced its participation in the Bank of America Securities Healthcare Conference 2024 where its president and chief financial officer will make a company presentation. The simultaneous webcast will be available on the company's website.
Full article2024-05-09T11:55:59Z
U.S. Blackline, Medpace Holdings, Roblox - XM neutral
ACVA.O A.N AEM.N ABNB.O ACI.N APOG.O ARIS.N ATXS.O AVTR.N BTG.A BALY.N BOH.N GOLD.N BCBP.O BRBR.N BL.O BKNG.O BOWL.N CACI.N CZR.O CRC.N CALX.N CCBG.O RNAC.O CVNA.N CWST.O CATY.O CHWY.N CLH.N CDE.N CRK.N ED.N COST.O CCI.N DC.A DDOG.O DVN.N FANG.O DIS.N DASH.O DTM.N DX.N EBAY.O EIX.N ENLC.N ENPH.O EPD.N EOG.N EQBK.N ELS.N EVRG.O EVRI.N ES.N EXFY.O FA.O FR.N FIVE.O FLUX.O FOR.N GLPI.O GEVO.O GBCI.N GDEN.O HBT.O HL.N HLT.N IBM.N ILMN.O INSM.O INTA.O INTC.O IGT.N IE.A KBR.N KNTK.N KLAC.O LBAI.O LXRX.O LFMD.O LYFT.O MAR.O MEDP.O MCBS.O MODN.N MP.N NTST.N NXT.O NICE.O NI.N NOG.N NWBI.O NWE.O NEM.N QCOM.O RRC.N O.N RVTY.N REXR.N RBLX.N RGLD.O STBA.O TNDM.O TMO.N TRIP.O UBER.N UPS.N VZ.N VERX.O VICI.N VTLE.N WTI.N WM.N WAT.N WAL.N WMB.N WTFC.O WK.N WPC.N YELP.N YUM.N ZG.O ZION.O
Summary: Multiple companies have had their stock target prices adjusted by various analysts, including Jefferies, Bernstein, and Raymond James.
Full article2024-04-23T13:32:29Z